Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia

Description

Experts explore the multifaceted landscape of metabolic dysfunction-associated steatotic liver disease (MASLD) in Asia, addressing regional epidemiology, risk factors, and clinical nuances to equip health care professionals and researchers with the knowledge needed to effectively address this growing public health concern. Presenters instruct participants to facilitate attainment of the expertise needed to identify and diagnose MASLD in Asian populations utilizing specific biomarkers and diagnostic tools. Experts explore advanced management and treatment approaches tailored to Asian patients with an emphasis on enhancing patient outcomes. Faculty also address the importance of culturally-sensitive health care delivery to ensure effective engagement with diverse Asian communities affected by MASLD.